Nicotinamide riboside
- Generic Name
- Nicotinamide riboside
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H15N2O5
- CAS Number
- 1341-23-7
- Unique Ingredient Identifier
- 0I8H2M0L7N
- Background
Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).
- Associated Conditions
- -
- Associated Therapies
- -
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
Phase 2
Recruiting
- Conditions
- Kidney DiseaseVascular DiseasesBlood PressureOxidative Stress
- Interventions
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 118
- Registration Number
- NCT04040959
- Locations
- 🇺🇸
UColorado, Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath